152 related articles for article (PubMed ID: 19657367)
1. Genetic polymorphisms of EPHX1, Gsk3beta, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma.
Durie BG; Van Ness B; Ramos C; Stephens O; Haznadar M; Hoering A; Haessler J; Katz MS; Mundy GR; Kyle RA; Morgan GJ; Crowley J; Barlogie B; Shaughnessy J
Leukemia; 2009 Oct; 23(10):1913-9. PubMed ID: 19657367
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma.
Kaiser M; Mieth M; Liebisch P; Oberländer R; Rademacher J; Jakob C; Kleeberg L; Fleissner C; Braendle E; Peters M; Stover D; Sezer O; Heider U
Eur J Haematol; 2008 Jun; 80(6):490-4. PubMed ID: 18331598
[TBL] [Abstract][Full Text] [Related]
3. CCN1 stimulated the osteoblasts via PTEN/AKT/GSK3β/cyclinD1 signal pathway in Myeloma Bone Disease.
Yan S; Liu H; Liu Z; Peng F; Jiang F; Li L; Fu R
Cancer Med; 2020 Jan; 9(2):737-744. PubMed ID: 31769620
[TBL] [Abstract][Full Text] [Related]
4. Dickkopf-related protein 1 expression in bone marrow of multiple myeloma patients: correlation with bone disease and plasma cell malignancy type.
Auziņa D; Beinaroviča I; Janicka-Kupra B; Lejniece S; Lejnieks A; Groma V
Exp Oncol; 2020 Dec; 42(4):285-288. PubMed ID: 33355872
[TBL] [Abstract][Full Text] [Related]
5. Dickkopf-1: a suitable target for the management of myeloma bone disease.
Gavriatopoulou M; Dimopoulos MA; Christoulas D; Migkou M; Iakovaki M; Gkotzamanidou M; Terpos E
Expert Opin Ther Targets; 2009 Jul; 13(7):839-48. PubMed ID: 19530987
[TBL] [Abstract][Full Text] [Related]
6. Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis.
Hao M; Zang M; Zhao L; Deng S; Xu Y; Qi F; An G; Qin Y; Sui W; Li F; Yang W; Li Z; Yi S; Zou D; Zhan F; Qiu L
Oncotarget; 2016 Apr; 7(15):19589-600. PubMed ID: 26995755
[TBL] [Abstract][Full Text] [Related]
7. Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping.
Johnson DC; Corthals S; Ramos C; Hoering A; Cocks K; Dickens NJ; Haessler J; Goldschmidt H; Child JA; Bell SE; Jackson G; Baris D; Rajkumar SV; Davies FE; Durie BG; Crowley J; Sonneveld P; Van Ness B; Morgan GJ
Blood; 2008 Dec; 112(13):4924-34. PubMed ID: 18805967
[TBL] [Abstract][Full Text] [Related]
8. Effect of HPSE and HPSE2 SNPs on the Risk of Developing Primary Paraskeletal Multiple Myeloma.
Ostrovsky O; Beider K; Magen H; Leiba M; Sanderson RD; Vlodavsky I; Nagler A
Cells; 2023 Mar; 12(6):. PubMed ID: 36980254
[TBL] [Abstract][Full Text] [Related]
9. C950T and C1181G osteoprotegerin gene polymorphisms in myeloma bone disease.
Sonmez M; Kazaz N; Yucel B; Topbas M; Ucar F
Hematology; 2014 Jun; 19(4):213-6. PubMed ID: 24074513
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the heparanase gene in multiple myeloma association with bone morbidity and survival.
Andersen NF; Vogel U; Klausen TW; Gimsing P; Gregersen H; Abildgaard N; Vangsted AJ
Eur J Haematol; 2015 Jan; 94(1):60-6. PubMed ID: 24954766
[TBL] [Abstract][Full Text] [Related]
11. Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder.
Inkster B; Nichols TE; Saemann PG; Auer DP; Holsboer F; Muglia P; Matthews PM
Arch Gen Psychiatry; 2009 Jul; 66(7):721-8. PubMed ID: 19581563
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism in ANRIL is associated with relapse in patients with multiple myeloma after autologous stem cell transplant.
Poi MJ; Li J; Sborov DW; VanGundy Z; Cho YK; Lamprecht M; Pichiorri F; Phelps MA; Hofmeister CC
Mol Carcinog; 2017 Jul; 56(7):1722-1732. PubMed ID: 28150872
[TBL] [Abstract][Full Text] [Related]
13. Genetic factors influencing the risk of multiple myeloma bone disease.
Johnson DC; Weinhold N; Mitchell J; Chen B; Stephens OW; Försti A; Nickel J; Kaiser M; Gregory WA; Cairns D; Jackson GH; Hoffmann P; Noethen MM; Hillengass J; Bertsch U; Barlogie B; Davis FE; Hemminki K; Goldschmidt H; Houlston RS; Morgan GJ
Leukemia; 2016 Apr; 30(4):883-8. PubMed ID: 26669972
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of serum levels of Dickkopf-1 (DKK-1) in monoclonal gammopathy of undetermined significance and multiple myeloma].
Ščudla V; Petrová P; Pika T; Lochman P; Minařík J; Bačovský J; Srovnalík K
Cas Lek Cesk; 2015; 154(4):181-8. PubMed ID: 26357861
[TBL] [Abstract][Full Text] [Related]
15. Prognostic variables for survival and skeletal complications in patients with multiple myeloma osteolytic bone disease.
Terpos E; Berenson J; Cook RJ; Lipton A; Coleman RE
Leukemia; 2010 May; 24(5):1043-9. PubMed ID: 20376081
[TBL] [Abstract][Full Text] [Related]
16. Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis.
de Rooy DP; Yeremenko NG; Wilson AG; Knevel R; Lindqvist E; Saxne T; Krabben A; Leijsma MK; Daha NA; Tsonaka S; Zhernakova A; Houwing-Duistermaat JJ; Huizinga TW; Toes RE; Baeten DL; Brouwer E; van der Helm-van Mil AH
Ann Rheum Dis; 2013 May; 72(5):769-75. PubMed ID: 23041840
[TBL] [Abstract][Full Text] [Related]
17. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma.
Tian E; Zhan F; Walker R; Rasmussen E; Ma Y; Barlogie B; Shaughnessy JD
N Engl J Med; 2003 Dec; 349(26):2483-94. PubMed ID: 14695408
[TBL] [Abstract][Full Text] [Related]
18. A haplotype of glycogen synthase kinase 3β is associated with early onset of unipolar major depression.
Saus E; Soria V; Escaramís G; Crespo JM; Valero J; Gutiérrez-Zotes A; Martorell L; Vilella E; Menchón JM; Estivill X; Gratacòs M; Urretavizcaya M
Genes Brain Behav; 2010 Oct; 9(7):799-807. PubMed ID: 20618448
[TBL] [Abstract][Full Text] [Related]
19. Microsomal epoxide hydrolase (EPHX1) polymorphisms are associated with aberrant promoter methylation of ERCC3 and hematotoxicity in benzene-exposed workers.
Xing C; Chen Q; Li G; Zhang L; Zheng M; Zou Z; Hou L; Wang QF; Liu X; Guo X
Environ Mol Mutagen; 2013 Jul; 54(6):397-405. PubMed ID: 23797950
[TBL] [Abstract][Full Text] [Related]
20. Interactions between SNPs affecting inflammatory response genes are associated with multiple myeloma disease risk and survival.
Nielsen KR; Rodrigo-Domingo M; Steffensen R; Baech J; Bergkvist KS; Oosterhof L; Schmitz A; Bødker JS; Johansen P; Vogel U; Vangsted A; Dybkær K; Bøgsted M; Johnsen HE
Leuk Lymphoma; 2017 Nov; 58(11):2695-2704. PubMed ID: 28393658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
